National Collaborative Issues Call to Action against COVID-19
National Collaborative Issues Call to Action against COVID-19
Melanie Ott helped shape recommendations for a unified plan to end the pandemic
Gladstone Experts COVID-19 Ott LabGladstone NOW: The Campaign Join Us on the Journey ✕
556 - 570 of 1364 Results Clear All
Melanie Ott helped shape recommendations for a unified plan to end the pandemic
Gladstone Experts COVID-19 Ott LabA scientist since childhood, Jain will now lead a lab at Gladstone to study the balance of oxygen levels in the human body
Institutional News News Release Profile Cardiovascular Disease Jain LabAn expert from Gladstone Institutes helps shape the new recommendations
Office of the Chief Operating Officer Gladstone Experts Institutional News Alzheimer’s DiseaseThe cells constantly survey the brain to prevent spontaneous seizures, Gladstone scientists discover
News Release Research (Publication) Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab Palop Lab ImagingThe findings could point toward new ways to prevent or treat one of the most common birth defects
News Release Research (Publication) Congenital Heart Disease Cardiovascular Disease Bruneau Lab Human Genetics Stem Cells/iPSCsForbes—In an article about the need for rapid testing to monitor and curb the COVID-19 pandemic, Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, explains the advantages of the CRISPR- and smartphone-based detection platform she developed with Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, and UC Berkeley Professor Dan Fletcher, PhD.
Gladstone Experts COVID-19 Data Science and Biotechnology Infectious Disease Doudna Lab Ott LabSan Francisco Business Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, discusses the rapid, smartphone-based Coronavirus detection assay her group recently described in the scientific publication Cell. The assay was developed by Graduate Student Parinaz Fozouni, in collaboration with the labs of Senior Scientist and Nobel Laureate Jennifer Doudna, PhD, and of UC Berkeley Bioengineering Professor Dan Fletcher, PhD.
Gladstone Experts COVID-19 Data Science and Biotechnology Infectious Disease Doudna Lab Ott LabA drug candidate found by Gladstone researchers could help prevent tens of thousands of heart surgeries every year
News Release Research (Publication) Heart Failure Cardiovascular Disease Srivastava Lab Theodoris Lab AI CRISPR/Gene Editing Disease Models Stem Cells/iPSCsA team of Gladstone and UCSF scientists used a large-scale genetic approach to map the structure of protein complexes in live cells
News Release Research (Publication) Data Science and Biotechnology Krogan Lab Protein InteractionSee what Gladstonians were up to in 2020
Communications HistoryThe new study points toward ways to treat not only COVID-19, but future coronaviruses that might emerge
News Release Research (Publication) COVID-19 Infectious Disease Krogan Lab Ott LabThe rapid, one-step mobile test could help combat the pandemic and fully reopen communities
News Release COVID-19 Data Science and Biotechnology Infectious Disease Doudna Lab Ott Lab CRISPR/Gene EditingEmployees often think it is up to the organization to launch DEI efforts, but in fact, everyone needs to participate.
Communications Gladstone Experts Profile DiversityGladstone remembers a loyal partner in its fight against Parkinson’s disease
Donor Stories Parkinson’s DiseaseLong-time Gladstone supporter helps scientists pursue Alzheimer’s disease research
Donor Stories Alzheimer’s Disease